Weir, E. and Paton, J. (2020) Mepolizumab in adolescents with severe eosinophilic asthma not eligible for omalizumab: one center’s early clinical experience. Journal of Asthma, 57(5), pp. 521-524. (doi: 10.1080/02770903.2019.1579833) (PMID:30795693)
|
Text
180774.pdf - Accepted Version 263kB |
Abstract
No abstract available.
| Item Type: | Articles (Letter) |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Paton, Dr James |
| Authors: | Weir, E., and Paton, J. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing |
| Journal Name: | Journal of Asthma |
| Publisher: | Taylor and Francis |
| ISSN: | 0277-0903 |
| ISSN (Online): | 1532-4303 |
| Published Online: | 22 February 2019 |
| Copyright Holders: | Copyright © 2019 Taylor & Francis |
| First Published: | First published in Journal of Asthma 57(5): 512-524 |
| Publisher Policy: | Reproduced in accordance with the copyright policy of the publisher |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details